SpringWorks Therapeutics (SWTX) Earnings Date & Reports
A.I. Advisor
published Earnings
SWTX is expected to report earnings to rise 46.81% to -79 cents per share on October 31
Q3'24
Est.
$-0.79
Q2'24
Beat
by $0.58
Q1'24
Missed
by $0.01
Q4'23
Missed
by $0.20
Q3'23
Beat
by $0.06
The last earnings report on August 07 showed earnings per share of -54 cents, beating the estimate of -112 cents. With 603.63K shares outstanding, the current market capitalization sits at 2.40B.
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer